Page last updated: 2024-10-16

gamma-aminobutyric acid and Brittle Bone Disease

gamma-aminobutyric acid has been researched along with Brittle Bone Disease in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research Excerpts

ExcerptRelevanceReference
"The short height and the reported bone fractures could be compatible with a mild form of osteogenesis imperfecta, previously described in one case associated with SUNCT."1.35SUNCT syndrome or first division trigeminal neuralgia associated with cerebellar hypoplasia. ( Bartolozzi, ML; Guidi, L; Panconesi, A, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Panconesi, A1
Bartolozzi, ML1
Guidi, L1

Other Studies

1 other study available for gamma-aminobutyric acid and Brittle Bone Disease

ArticleYear
SUNCT syndrome or first division trigeminal neuralgia associated with cerebellar hypoplasia.
    The journal of headache and pain, 2009, Volume: 10, Issue:6

    Topics: Amines; Arnold-Chiari Malformation; Carbamazepine; Cerebellum; Cranial Fossa, Posterior; Cyclohexane

2009